These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26812023)

  • 1. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
    Ritacco I; Mazzone G; Russo N; Sicilia E
    Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the stability of Pt(IV) pro-drugs with haloacetato ligands in the axial positions.
    Wexselblatt E; Raveendran R; Salameh S; Friedman-Ezra A; Yavin E; Gibson D
    Chemistry; 2015 Feb; 21(7):3108-14. PubMed ID: 25529335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.
    Wexselblatt E; Yavin E; Gibson D
    Angew Chem Int Ed Engl; 2013 Jun; 52(23):6059-62. PubMed ID: 23686723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Role of Axial Ligands in Modulating the Biopharmaceutical Outcomes of Cisplatin(IV) Derivatives.
    Date T; Kuche K; Ghadi R; Kumar P; Jain S
    Mol Pharm; 2022 May; 19(5):1325-1337. PubMed ID: 35437994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt
    Kastner A; Poetsch I; Mayr J; Burda JV; Roller A; Heffeter P; Keppler BK; Kowol CR
    Angew Chem Int Ed Engl; 2019 May; 58(22):7464-7469. PubMed ID: 30870571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
    Aher S; Zhu J; Bhagat P; Borse L; Liu X
    Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
    Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
    Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(IV) Complexes of
    Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
    Dabbish E; Ponte F; Russo N; Sicilia E
    Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(IV) prodrugs.
    Chen S; Ng KY; Zhou Q; Yao H; Deng Z; Tse MK; Zhu G
    Dalton Trans; 2022 Jan; 51(3):885-897. PubMed ID: 34927657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
    Göschl S; Varbanov HP; Theiner S; Jakupec MA; Galanski MS; Keppler BK
    J Inorg Biochem; 2016 Jul; 160():264-74. PubMed ID: 27055943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.
    Theiner S; Grabarics M; Galvez L; Varbanov HP; Sommerfeld NS; Galanski MS; Keppler BK; Koellensperger G
    Dalton Trans; 2018 Apr; 47(15):5252-5258. PubMed ID: 29560976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin.
    Zajac J; Kostrhunova H; Novohradsky V; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2016 Mar; 156():89-97. PubMed ID: 26780576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.